miR-122, a paradigm for the role of microRNAs in the liver - PubMed (original) (raw)
Review
doi: 10.1016/j.jhep.2008.01.019. Epub 2008 Feb 12.
Affiliations
- PMID: 18291553
- DOI: 10.1016/j.jhep.2008.01.019
Free article
Review
miR-122, a paradigm for the role of microRNAs in the liver
Muriel Girard et al. J Hepatol. 2008 Apr.
Free article
Abstract
Recent studies have uncovered profound and unexpected roles for a family of tiny regulatory RNAs, known as microRNAs (miRNAs), in the control of diverse aspects of hepatic function and dysfunction, including hepatocyte growth, stress response, metabolism, viral infection and proliferation, gene expression, and maintenance of hepatic phenotype. In liver cancer, misexpression of specific miRNAs suggests diagnostic and prognostic significance. Here, we review the biology of the most abundant miRNA in human liver, miR-122, and consider the diversity of its roles in the liver. We provide a compilation of all miRNAs expressed in the liver, and consider some possible therapeutic opportunities for exploiting miRNAs in the different settings of liver diseases.
Similar articles
- Meta-regulation: microRNA regulation of glucose and lipid metabolism.
Lynn FC. Lynn FC. Trends Endocrinol Metab. 2009 Nov;20(9):452-9. doi: 10.1016/j.tem.2009.05.007. Epub 2009 Sep 30. Trends Endocrinol Metab. 2009. PMID: 19800254 Review. - MicroRNAs: role in cardiovascular biology and disease.
Zhang C. Zhang C. Clin Sci (Lond). 2008 Jun;114(12):699-706. doi: 10.1042/CS20070211. Clin Sci (Lond). 2008. PMID: 18474027 Review. - MicroRNAs in development and disease.
Erson AE, Petty EM. Erson AE, et al. Clin Genet. 2008 Oct;74(4):296-306. doi: 10.1111/j.1399-0004.2008.01076.x. Epub 2008 Aug 18. Clin Genet. 2008. PMID: 18713256 Review. - MicroRNAs in normal and malignant hematopoiesis.
Garzon R, Croce CM. Garzon R, et al. Curr Opin Hematol. 2008 Jul;15(4):352-8. doi: 10.1097/MOH.0b013e328303e15d. Curr Opin Hematol. 2008. PMID: 18536574 Review. - Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy?
Tong AW, Nemunaitis J. Tong AW, et al. Cancer Gene Ther. 2008 Jun;15(6):341-55. doi: 10.1038/cgt.2008.8. Epub 2008 Mar 28. Cancer Gene Ther. 2008. PMID: 18369380 Review.
Cited by
- MicroRNAs in alcoholic liver disease.
Szabo G, Satishchandran A. Szabo G, et al. Semin Liver Dis. 2015 Feb;35(1):36-42. doi: 10.1055/s-0034-1397347. Epub 2015 Jan 29. Semin Liver Dis. 2015. PMID: 25632933 Free PMC article. Review. - A panel of serum microRNAs as specific biomarkers for diagnosis of compound- and herb-induced liver injury in rats.
Su YW, Chen X, Jiang ZZ, Wang T, Wang C, Zhang Y, Wen J, Xue M, Zhu D, Zhang Y, Su YJ, Xing TY, Zhang CY, Zhang LY. Su YW, et al. PLoS One. 2012;7(5):e37395. doi: 10.1371/journal.pone.0037395. Epub 2012 May 18. PLoS One. 2012. PMID: 22624025 Free PMC article. - Effects of microRNAs on fucosyltransferase 8 (FUT8) expression in hepatocarcinoma cells.
Bernardi C, Soffientini U, Piacente F, Tonetti MG. Bernardi C, et al. PLoS One. 2013 Oct 9;8(10):e76540. doi: 10.1371/journal.pone.0076540. eCollection 2013. PLoS One. 2013. PMID: 24130780 Free PMC article. - MicroRNAs and liver cancer associated with iron overload: therapeutic targets unravelled.
Greene CM, Varley RB, Lawless MW. Greene CM, et al. World J Gastroenterol. 2013 Aug 28;19(32):5212-26. doi: 10.3748/wjg.v19.i32.5212. World J Gastroenterol. 2013. PMID: 23983424 Free PMC article. Review. - Serum microRNAs; miR-30c-5p, miR-223-3p, miR-302c-3p and miR-17-5p could be used as novel non-invasive biomarkers for HCV-positive cirrhosis and hepatocellular carcinoma.
Oksuz Z, Serin MS, Kaplan E, Dogen A, Tezcan S, Aslan G, Emekdas G, Sezgin O, Altintas E, Tiftik EN. Oksuz Z, et al. Mol Biol Rep. 2015 Mar;42(3):713-20. doi: 10.1007/s11033-014-3819-9. Epub 2014 Nov 13. Mol Biol Rep. 2015. PMID: 25391771
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical